The role of gut hormones in controlling the food intake. What is their role in emerging diseases?

Endocrinologia y Nutricion

Volumn 59, Issue 3, 2012, Pages 197-206

  Del Prete, Anna ^a   Iadevaia, Maddalena ^a   Loguercio, Carmelina ^a  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

Author keywords

Cholecystokinin (CCK); Ghrelin; Glucagon like peptide 1 (GLP 1); Gut hormones; Non alcoholic fatty liver disease (NAFLD); Obesity; Peptide YY (PYY)

Indexed keywords

ACYLTRANSFERASE; AMYLIN; CHOLECYSTOKININ; CHOLECYSTOKININ A RECEPTOR; CHOLECYSTOKININ A RECEPTOR ANTAGONIST; EXENDIN 4; FATTY ACID; GASTROINTESTINAL HORMONE; GASTROINTESTINAL POLYPEPTIDE; GHRELIN; GHRELIN O ACYLTRANSFERASE; GLUCAGON LIKE PEPTIDE 1; HEMOGLOBIN A1C; MEDIUM CHAIN FATTY ACID; OXYNTOMODULIN; PANCREAS POLYPEPTIDE; PEPTIDE YY; UNCLASSIFIED DRUG;

ANOREXIA; BARIATRIC SURGERY; BLOOD BRAIN BARRIER; CALORIC INTAKE; ENERGY BALANCE; ENZYME RELEASE; FEEDING BEHAVIOR; FIBER; FOOD INTAKE; GLYCEMIC CONTROL; HORMONE BLOOD LEVEL; HORMONE RELEASE; HORMONE SYNTHESIS; HUMAN; INSULIN SENSITIVITY; LIVER CIRRHOSIS; LIVER DISEASE; NEUROMODULATION; NON INSULIN DEPENDENT DIABETES MELLITUS; NONALCOHOLIC FATTY LIVER; NONHUMAN; NUTRIENT; OBESITY; PATHOPHYSIOLOGY; PROTEIN EXPRESSION; SATIETY; SHORT SURVEY; SIGNAL TRANSDUCTION; VAGUS TONE;

ANIMALS; ARCUATE NUCLEUS; BRAIN STEM; CHOLECYSTOKININ; EATING; ENERGY INTAKE; ENERGY METABOLISM; FATTY LIVER; FEEDING BEHAVIOR; GASTROINTESTINAL HORMONES; GHRELIN; GLUCAGON-LIKE PEPTIDE 1; HUMANS; HUNGER; HYPERPHAGIA; OBESITY; PEPTIDE YY; SATIATION;

EID: 84858280512     PISSN: 15750922     EISSN: 15792021     Source Type: Journal    
DOI: 10.1016/j.endonu.2011.11.007     Document Type: Short Survey

References (105)

1. Harrold J.A. Hypothalamic control of energy balance. Curr Drug Targets 2004, 5:207-219.
2. Crespo M.A., González Matías L.C., Lozano M.G., Paz S.F., Pérez M.R., Gago E.V., Ferrer F.M. Gastrointestinal hormones in food intake control. Endocrinol Nutr 2009, 56:317-330. [review, in Spanish].
3. Suzuki K., Simpson K.A., Minnion J.S., Shillito J.C., Bloom S.R. The role of gut hormones and the hypothalamus in appetite regulation. Endocr J 2010, 57:359-372. [Epub 2010 April 14].
4. Moran T.H. Gut peptides in the control of food intake. Int J Obes (Lond) 2009, 33(Suppl. 1):S7-S10. [review].
5. Muccioli G., Tschöp M., Papotti M., Deghenghi R., Heiman M., Ghigo E. Neuroendocrine and peripheral activities of ghrelin: implications in metabolism and obesity. Eur J Pharmacol 2002, 440:235-254.
6. Gutierrez J.A., Solenberg P.J., Perkins D.R., Willency J.A., Knierman M.D., Jin Z., Witcher D.R., Luo S., Onyia J.E., Hale J.E. Ghrelin octanoylation mediated by an orphan lipid transferase. Proc Natl Acad Sci U S A 2008, 105:6320-6325. [Epub 2008 April 28].
7. Van Der Lely A.J., Tschop M., Heiman M.L., Ghigo E. Biological, physiological, pathophysiological, and pharmacological aspects of ghrelin. Endocr Rev 2004, 25:426-457.
8. Gil-Campos M., Aguilera C.M., Cañete R., Gil A. Ghrelin: a hormone regulating food intake and energy homeostasis. Br J Nutr 2006, 96:201-226.
9. Wren A.M., Seal L.J., Cohen M.A., Brynes A.E., Frost G.S., Murphy K.G., Dhillo W.S., Ghatei M.A., Bloom S.R. Ghrelin enhances appetite and increases food intake in humans. J Clin Endocrinol Metab 2001, 86:5992-5995.
10. Cummings D.E., Frayo R.S., Marmonier C., Aubert R., Chapelot D. Plasma ghrelin levels and hunger scores in humans initiating meals voluntarily without time- and food-related cues. Am J Physiol Endocrinol Metab 2004, 287:E297-E304.
11. Miura H., Tsuchiya N., Sasaki I., Kikuchi M., Kojima M., Kangawa K., Hasegawa Y., Ohnami Y. Changes in plasma ghrelin and growth hormone concentrations in mature Holstein cows and three-month-old calves. J Anim Sci 2004, 82:1329-1333.
12. Callahan H.S., Cummings D.E., Pepe M.S., Breen P.A., Matthys C.C., Weigle D.S. Postprandial suppression of plasma ghrelin level is proportional to ingested caloric load but does not predict intermeal interval in humans. J Clin Endocrinol Metab 2004, 89:1319-1324.
13. Monteleone P., Bencivenga R., Longobardi N., Serritella C., Maj M. Differential responses of circulating ghrelin to high-fat or high carbohydrate meal in healthy women. J Clin Endocrinol Metab 2003, 88:5510-5514.
14. Overduin J., Frayo R.S., Grill H.J., Kaplan J.M., Cummings D.E. Role of the duodenum and macronutrient type in ghrelin regulation. Endocrinology 2005, 146:845-850.
15. Wren A.M., Small C.J., Ward H.L., Murphy K.G., Dakin C.L., Taheri S., Kennedy A.R., Roberts G.H., Morgan D.G., Ghatei M.A., Bloom S.R. The novel hypothalamic peptide ghrelin stimulates food intake and growth hormone secretion. Endocrinology 2000, 141:4325-4328.
16. Moran T.H., Kinzig K.P. Gastrointestinal satiety signals II. Cholecystokinin. Am J Physiol Gastrointest Liver Physiol 2004, 286:G183-G188.
17. Little T.J., Horowitz M., Feinle-Bisset C. Role of cholecystokinin in appetite control and body weight regulation. Obes Rev 2005, 6:297-306.
18. Bi S., Scott K.A., Kopin A.S., Moran T.H. Differential roles for cholecystokinin A receptors in energy balance in rats and mice. Endocrinology 2004, 14:3873-3880.
19. Dockray G. Gut endocrine secretions and their relevance to satiety. Curr Opin Pharmacol 2004, 4:557-560.
20. Herness S., Zhao F.L. The neuropeptides CCK and NPY and the changing view of cell-to-cell communication in the taste bud. Physiol Behav 2009, 97:581-591. [review, Epub 2009 April 5].
21. Beglinger C., Degen L., Matzinger D., D'Amato M., Drewe J. Loxiglumide, a CCK-A receptor antagonist, stimulates calorie intake and hunger feelings in humans. Am J Physiol Regul Integr Comp Physiol 2001, 280:R1149-R1154.
22. Larsen P.J., Fledelius C., Knudsen L.B., Tang-Christensen M. Systemic administration of the long-acting GLP-1 derivative NN2211 induces lasting and reversible weight loss in both normal and obese rats. Diabetes 2001, 50:2530-2539.
23. Neary N.M., Small C.J., Druce M.R., et al. Peptide YY3-36 and glucagon-like peptide-17-36 inhibit food intake additively. Endocrinology 2005, 146:5120-5127.
24. Ballantyne G.H. Peptide YY(1-36) and peptide YY(3-36): part I. Distribution, release and actions. Obes Surg 2006, 16:651-658. [review].
25. Martin J.R. Peptide YY administration into the posterior hypothalamic nucleus of the rat evokes cardiovascular changes by non-adrenergic, non-cholinergic mechanisms. Auton Autacoid Pharmacol 2005, 25:53-67.
26. Essah P.A., Levy J.R., Sistrun S.N., Kelly S.M., Nestler J.E. Effect of macronutrient composition on postprandial peptide YY levels. J Clin Endocrinol Metab 2007, 92:4052-4055. [Epub 2007 August 28].
27. Schonhoff S., Baggio L., Ratineau C., Ray S.K., Lindner J., Magnuson M.A., Drucker D.J., Leiter A.B. Energy homeostasis and gastrointestinal endocrine differentiation do not require the anorectic hormone peptide YY. Mol Cell Biol 2005, 25:4189-4199.
28. Baggio L.L., Drucker D.J. Biology of incretins: GLP-1 and GIP. Gastroenterology 2007, 132:2131-2157. [review].
29. Suzuki K., Simpson K.A., Minnion J.S., Shillito J.C., Bloom S.R. The role of gut hormones and the hypothalamus in appetite regulation. Endocr J 2010, 57:359-372. [review, Epub 2010 April 14].
30. Chaudhri O.B., Field B.C. Bloom SR Gastrointestinal satiety signals. Int J Obes (Lond) 2008, 32(Suppl. 7):S28-S31. [review].
31. Cohen M.A., Ellis S.M., Le Roux C.W., Batterham R.L., Park A., Patterson M., Frost G.S., Ghatei M.A., Bloom S.R. Oxyntomodulin suppresses appetite and reduces food intake in humans. J Clin Endocrinol Metab 2003, 88:4696-4701.
32. Burcelin R., Dejager S. GLP-1: what is known, new and controversial in 2010?. Diabetes Metab 2010, 36(6 Pt. 1):503-509. [Epub 2010 November 13].
33. Shyangdan D.S., Royle P.L., Clar C., Sharma P., Waugh N.R. Glucagon-like peptide analogues for type 2 diabetes mellitus: systematic review and meta-analysis. BMC Endocr Disord 2010, 10:20.
34. Verdich C., Flint A., Gutzwiller J.P., Naslund E., Beglinger C., Hellstrom P.M., Long S.J., Morgan L.M., Holst J.J., Astrup A. A meta-analysis of the effect of glucagon-like peptide-1 (7-36) amide on ad libitum Energy intake in humans. J Clin Endocrinol Metab 2001, 86:4382-4389.
35. Wynne K., Field B.C., Bloom S.R. The mechanism of action for oxyntomodulin in the regulation of obesity. Curr Opin Investig Drugs 2010, 11:1151-1157. [review].
36. Blom W.A.M., Stafleu A., de Graaf C., Kok F.J., Schaafsma G., Hendriks H.F.J. Ghrelin response to carbohydrate-enriched breakfast is related to insulin. Am J Clin Nutr 2005, 81:367-375.
37. Greenman Y., Golani N., Gilad S., Yaron M., Limor R., Stern N. Ghrelin secretion is modulated in a nutrient- and gender-specific manner. Clin Endocrinol (Oxf) 2004, 60:382-388.
38. Erdmann J., Leibl M., Wagenpfeil S., Lippl F., Schusdziarra V. Ghrelin response to protein and carbohydrate meals in relation to food intake and glycerol levels in obese subjects. Regul Pept 2006, 135:23-29.
39. Weickert M.O., Spranger J., Holst J.J., Otto B., Koebnick C., Möhlig M., Pfeiffer A.F. Wheat-fibre-induced changes of postprandial peptide YY and ghrelin responses are not associated with acute alterations of satiety. Br J Nutr 2006, 96:795-798.
40. Groschl M., Knerr I., Topf H.G., Schmid P., Rascher W., Rauh M. Endocrine responses to the oral ingestion of a physiological dose of essential amino acids in humans. J Endocrinol 2003, 179:237-244.
41. Blom W.A., Lluch A., Stafleu A., et al. Effect of a high-protein breakfast on the postprandial ghrelin response. Am J Clin Nutr 2006, 83:211-220.
42. Erdmann J., Topsch R., Lippl F., Gussmann P., Schusdziarra V. Postprandial response of plasma ghrelin levels to various test meals in relation to food intake, plasma insulin, and glucose. J Clin Endocrinol Metab 2004, 89:3048-3054.
43. Aziz A., Anderson G.H. The effects of dairy components on food intake and satiety. Functional dairy products 2007, 19-45. Woodhead Publishing Limited and CRC Press LLC, Cambridge. M. Saarela (Ed.).
44. Otto B., HeldweinW, Otto C., Huptas S., Parhofer K.G. Effect of a high-fat meal on the postprandial ghrelin response. Am J Clin Nutr 2006, 84:664-665.
45. Feinle-Bisset C., Patterson M., Ghatei M.A., Bloom S.R., Horowitz M. Fat digestion is required for suppression of ghrelin and stimulation of peptide YY and pancreatic polypeptide secretion by intraduodenal lipid. Am J Physiol Endocrinol Metab 2005, 289:E948-E953.
46. Little T.J., Feinle-Bisset C. Oral and gastrointestinal sensing of dietary fat and appetite regulation in humans: modification by diet and obesity. Front Neurosci 2010, 4:178.
47. Bowen J., Noakes M., Trenerry C., Clifton P.M. Energy intake, ghrelin, and cholecystokinin after different carbohydrate and protein preloads in overweight men. J Clin Endocrinol Metab 2006, 91:1477-1483.
48. Seimon R.V., Feltrin K.L., Meyer J.H., Brennan I.M., Wishart J.M., Horowitz M., Feinle-Bisset C. Effects of varying combinations of intraduodenal lipid and carbohydrate on antropyloroduodenal motility, hormone release, and appetite in healthy males. Am J Physiol Regul Integr Comp Physiol 2009, 296:R912-R920. [Epub 2009 February 11].
49. Heini A.F., Lara-Castro C., Schneider H., Kirk K.A., Considine R.V., Weinsier R.L. Effect of hydrolyzed guar fiber on fasting and postprandial satiety and satiety hormones: a double-blind, placebo-controlled trial during controlled weight loss. Int J Obes Relat Metab Disord 1998, 22:906-909.
50. Bourdon I., Yokoyama W., Davis P., Hudson C., Backus R., Richter D., Knuckles B., Schneeman B.O. Postprandial lipid, glucose, insulin, and cholecystokinin responses in men fed barley pasta enriched with beta-glucan. Am J Clin Nutr 1999, 69:55-63.
51. Bourdon I., Olson B., Backus R., Richter B.D., Davis P.A., Schneeman B.O. Beans, as a source of dietary fiber, increase cholecystokinin and apolipoprotein b48 response to test meals in men. J Nutr 2001, 131:1485-1490.
52. Hall W.L., Millward D.J., Long S.J., Morgan L.M. Casein and whey exert different effects on plasma amino acid profiles, gastrointestinal hormone secretion and appetite. Br J Nutr 2003, 89:239-248.
53. Bray G.A. Afferent signals regulating food intake. Proc Nutr Soc 2000, 59:373-384.
54. McLaughlin J., Grazia Lucà M., Jones M.N., D'Amato M., Dockray G.J., Thompson D.G. Fatty acid chain length determines cholecystokinin secretion and effect on human gastric motility. Gastroenterology 1999, 116:46-53.
55. Matzinger D., Degen L., Drewe J., Meuli J., Duebendorfer R., Ruckstuhl N., D'Amato M., Rovati L., Beglinger C. The role of long chain fatty acids in regulating food intake and cholecystokinin release in humans. Gut 2000, 46:688-693.
56. Feltrin K.L., Little T.J., Meyer J.H., Horowitz M., Smout A.J.P.M., Wishart J., Pilichiewicz A.N., Rades T., Chapman I.M., Feinle-Bisset C. Effects of intraduodenal fatty acids on appetite, antropyloroduodenal motility, and plasma CCK and GLP-1 in humans vary with their chain length. Am J Physiol Regul Integr Comp Physiol 2004, 287:R524-R533.
57. Robertson M.D., Henderson R.A., Vist G.E., Rumsey R.D. Extended effects of evening meal carbohydrate-to-fat ratio on fasting and postprandial substrate metabolism. Am J Clin Nutr 2002, 75:505-510.
58. Donovan M.J., Paulino G., Raybould H.E. CCK(1) receptor is essential for normal meal patterning in mice fed high fat diet. Physiol Behav 2007, 92:969-974.
59. Cox H.M. Peptide YY: a neuroendocrine neighbor of note. Peptides 2007, 28:345-351.
60. Essah P.A., Levy J.R., Sistrun S.N., Kelly S.M., Nestler J.E. Effect of macronutrient composition on postprandial peptide YY levels. J Clin Endocrinol Metab 2007, 92:4052-4055.
61. Lomenick J.P., Melguizo M.S., Mitchell S.L., Summar M.L., Anderson J.W. Effects of meals high in carbohydrate, protein, and fat on ghrelin and peptide YY secretion in prepubertal children. J Clin Endocrinol Metab 2009, 94:4463-4471. [Epub 2009 October 9].
62. MacIntosh C.G., Andrews J.M., Jones K.L., Wishart J.M., Morris H.A., Jansen J.B.M.J., Morley J.E., Horowitz M., Chapman I.M. Effects of age on concentrations of plasma cholecystokinin, glucagon-like peptide 1, and peptide YY and their relation to appetite and pyloric motility. Am J Clin Nutr 1999, 69:999-1006.
63. Erlanson-Albertsson C. Fat-rich food palatability and appetite regulation. Fat detection: taste, texture, and post ingestive effects 2010, CRC Press, Boca Raton, FL, [chapter 14]. J.P. Montmayeur, J. le Coutre (Eds.).
64. Helou N., Obeid O., Azar S.T., Hwalla N. Variation of postprandial PYY 3-36 response following ingestion of differing macronutrient meals in obese females. Ann Nutr Metab 2008, 52:188-195. [Epub 2008 June 11].
65. Pedersen-Bjergaard U., Host U., Kelbaek H., Schifter S., Rehfeld J.F., Faber J., Christensen N.J. Influence of meal composition on postprandial peripheral plasma concentrations of vasoactive peptides in man. Scand J Clin Lab Invest 1996, 56:497-503.
66. Feltrin K.L., Patterson M., Ghatei M.A., Bloom S.R., Meyer J.H., Horowitz M., Feinle-Bisset C. Effect of fatty acid chain length on suppression of ghrelin and stimulation of PYY, GLP-2 and PP secretion in healthy men. Peptides 2006, 27:1638-1643. [Epub 2006 March 23].
67. Serrano P., Yago M.D., Manas M.D., Calpena R., Mataix J., Martinez-Victoria E. Influence of type of dietary fat (olive and sunflower oil) upon gastric acid secretion and release of gastrin, somatostatin, and peptide YY in man. Dig Dis Sci 1997, 42:626-633.
68. Karhunen L.J., Juvonen K.R., Flander S.M., Liukkonen K.H., Lähteenmäki L., Siloaho M., Laaksonen D.E., Herzig K.H., Uusitupa M.I., Poutanen K.S. A psyllium fiber-enriched meal strongly attenuates postprandial gastrointestinal peptide release in healthy young adults. J Nutr 2010, 140:737-744. [Epub 2010 February 10].
69. Weickert M.O., Spranger J., Holst J.J., Otto B., Koebnick C., Möhlig M., Pfeiffer A.F. Br Wheat-fibre-induced changes of postprandial peptide YY and ghrelin responses are not associated with acute alterations of satiety. J Nutr 2006, 96:795-798.
70. Calbet J.A., Holst J.J. Gastric emptying, gastric secretion and enterogastrone response after administration of milk proteins or their peptide hydrolysates in humans. Eur J Nutr 2004, 43:127-139. [Epub 2004 January 6].
71. Wu T., Rayner C.K., Jones K., Horowitz M. Dietary effects on incretin hormone secretion. Vitam Horm 2010, 84:81-110. [Review].
72. Rayner C.K., Park H.S., Wishart J.M., Kong M., Doran S.M., Horowitz M. Effects of intraduodenal glucose and fructose on antropyloric motility and appetite in healthy humans. Am J Physiol Regul Integr Comp Physiol 2000, 278:R360-R366.
73. Kong M.F., Chapman I., Goble E., Wishart J., Wittert G., Morris H., Horowitz M. Effects of oral fructose and glucose on plasma GLP-1 and appetite in normal subjects. Peptides 1999, 20:545-551.
74. Weickert M.O., Mohlig M., Koebnick C., Holst J.J., Namsolleck P., Ristow M., Osterhoff M., Rochlitz H., Rudovich N., Spranger J., Pfeiffer A.F. Impact of cereal fibre on glucose-regulating factors. Diabetologia 2005, 48:2343-2353. [Epub 2005 September 20].
75. Wang Z.Q., Zuberi A.R., Zhang X.H., Macgowan J., Qin J., Ye X., Son L., Wu Q., Lian K., Cefalu W.T. Effects of dietary fibers on weight gain, carbohydrate metabolism, and gastric ghrelin gene expression in mice fed a high-fat diet. Metabolism 2007, 56:1635-1642.
76. Raben A., Agerholm-Larsen L., Flint A., Holst J.J., Astrup A. Meals with similar energy densities but rich in protein, fat, carbohydrate, or alcohol have different effects on energy expenditure and substrate metabolism but not on appetite and energy intake. Am J Clin Nutr 2003, 77:91-100.
77. Veldhorst M.A., Nieuwenhuizen A.G., Hochstenbach-Waelen A., van Vught A.J., Westerterp K.R., Engelen M.P., Brummer R.J., Deutz N.E., Westerterp-Plantenga M.S. Dose-dependent satiating effect of whey relative to casein or soy. Physiol Behav 2009, 96:675-682.
78. Rocca A.S., LaGreca J., Kalitsky J., Brubaker P.L. Monounsaturated fatty acid diets improve glycemic tolerance through increased secretion of glucagon-like peptide-1. Endocrinology 2001, 142:1148-1155.
79. Brynes A.E., Edwards C.M., Jadhav A., Ghatei M.A., Bloom S.R., Frost G.S. Diet-induced change in fatty acid composition of plasma triacylglycerols is not associated with change in glucagon-like peptide 1 or insulin sensitivity in people with type 2 diabetes. Am J Clin Nutr 2000, 72:1111-1118.
80. Williams D.L., Hyvarinen N., Lilly N., Kay K., Dossat A., Parise E., Torregrossa A.M. Maintenance on a high-fat diet impairs the anorexic response to glucagon-like-peptide-1 receptor activation. Physiol Behav 2011, 103:557-564. [Epub 2011 April 15].
81. English P.J., Ghatei M.A., Malik I.A., Bloom S.R., Wilding J.P. Food fails to suppress ghrelin levels in obese humans. J Clin Endocrinol Metab 2002, 87:2984.
82. Adams C.E., Greenway F.L., Brantley P.J. Lifestyle factors and ghrelin: critical review and implications for weight loss maintenance. Obes Rev 2011, 12:e211-e218. [review]. 10.1111/j.1467-789X.2010.00776.x.
83. Feigerlová E., Diene G., Conte-Auriol F., Molinas C., Gennero I., Salles J.P., Arnaud C., Tauber M. Hyperghrelinemia precedes obesity in Prader-Willi syndrome. J Clin Endocrinol Metab 2008, 93:2800-2805. [Epub 2008 May 6].
84. Moran T.H., Bi S. Hyperphagia and obesity in OLETF rats lacking CCK-1 receptors. Philos Trans R Soc Lond B Biol Sci 2006, 361:1211-1218. [review].
85. Arora S., Anubhuti Role of neuropeptides in appetite regulation and obesity-a review. Neuropeptides 2006, 40:375-401. [Epub 2006 August 28].
86. Batterham R.L., Cohen M.A., Ellis S.M., Le Roux C.W., Withers D.J., Frost G.S., Ghatei M.A., Bloom S.R. Inhibition of food intake in obese subjects by peptide YY3-36. N Engl J Med 2003, 349:941-948.
87. Alvarez B.M., Borque M., Martinez-Sarmiento J., Aparicio E., Hernandez C., Cabrerizo L., Fernandez-Represa J.A. Peptide YY secretion in morbidly obese patients before and after vertical banded gastroplasty. Obes Surg 2002, 12:324-327.
88. Stock S., Leichner P., Wong A.C., Ghatei M.A., Kieffer T.J., Bloom S.R., Chanoine J.P.J. Ghrelin, peptide YY, glucose-dependent insulinotropic polypeptide, and hunger responses to a mixed meal in anorexic, obese, and control female adolescents. Clin Endocrinol Metab 2005, 90:2161-2168. [Epub 2005 January 18].
89. Korner J., Bessler M., Cirilo L.J., Conwell I.M., Daud A., Restuccia N.L., Wardlaw S.L. Effects of Roux-en-Y gastric bypass surgery on fasting and postprandial concentrations of plasma ghrelin, peptide YY, and insulin. J Clin Endocrinol Metab 2005, 90:359-365.
90. Karra E., Chandarana K., Batterham R.L. The role of peptide YY in appetite regulation and obesity. J Physiol 2009, 587(Pt. 1):19-25. [Epub 2008 December 8].
91. Flint A., Raben A., Ersbøll A.K., Holst J.J., Astrup A. The effect of physiological levels of glucagon-like peptide-1 on appetite, gastric emptying, energy and substrate metabolism in obesity. Int J Obes Relat Metab Disord 2001, 25:781-792.
92. Zander M., Madsbad S., Madsen J.L., Holst J.J. Effect of 6-week course of glucagon-like peptide 1 on glycaemic control, insulin sensitivity, and beta-cell function in type 2 diabetes: a parallel-group study. Lancet 2002, 359:824-830.
93. Ruffo M., Hribal M.L., Sesti G. Glucagon-like peptide-1 analogues: effects on body weight and glycemia. G Ital Cardiol (Rome) 2010, 11(12 Suppl. 2):12S-17S. [review, in Italian].
94. le Roux C.W., Welbourn R., Werling M., Osborne A., Kokkinos A., Laurenius A., Lönroth H., Fändriks L., Ghatei M.A., Bloom S.R., Olbers T. Gut hormones as mediators of appetite and weight loss after Roux-en-Y gastric bypass. Ann Surg 2007, 246:780-785.
95. Lewis J.R., Mohanty S.R. Nonalcoholic fatty liver disease: a review and update. Dig Dis Sci 2010, 55:560-578. [review, Epub 2010 January 26].
96. Shyangdan D., Clar C., Ghouri N., Henderson R., Gurung T., Preiss D., Sattar N., Fraser A., Waugh N Insulin sensitisers in the treatment of non-alcoholic fatty liver disease: a systematic review. Health Technol Assess 2011, 15:1-116.
97. Stein L.L., Dong M.H., Loomba R. Insulin sensitizers in nonalcoholic fatty liver disease and steatohepatitis: current status. Adv Ther 2009, 26:893-907. [Epub 2009 November 16].
98. Ding X., Saxena N.K., Lin S., Gupta N.A., Anania F.A. Exendin-4, a glucagon-like protein-1 (GLP-1) receptor agonist, reverses hepatic steatosis in ob/ob mice. Hepatology 2006, 43:173-181.
99. Siegel E.G., Seidenstücker A., Gallwitz B., Schmitz F., Reinecke-Lüthge A., Klöppel G., Fölsch U.R., Schmidt W.E. Insulin secretion defects in liver cirrhosis can be reversed by glucagon-like peptide-1. J Endocrinol 2000, 164:13-19.
100. El-Shehaby A.M., Obaia E.M., Alwakil S.S., Hiekal A.A. Total and acylated ghrelin in liver cirrhosis: correlation with clinical and nutritional status. Scand J Clin Lab Invest 2010, 70:252-258.
101. Tacke F., Brabant G., Kruck E., Horn R., Schoffski P., Hecker H., Manns M.P., Trautwein C. Ghrelin in chronic liver disease. J Hepatol 2003, 38:447-454.
102. Marchesini G., Bianchi G., Lucidi P., Villanova N., Zoli M., De Feo P. Plasma ghrelin concentrations, food intake, and anorexia in liver failure. J Clin Endocrinol Metab 2004, 89:2136-2141. 10.1210/jc.2003-031771.
103. Kalaitzakis E., Bosaeus I., Ohman L., Bjornsson E. Altered postprandial glucose, insulin, leptin, and ghrelin in liver cirrhosis: correlations with energy intake and resting energy expenditure. Am J Clin Nutr 2007, 85:808-815.
104. Diz-Lois M.T., Garcia-Buela J., Suarez F., Sangiao-Alvarellos S., Vidal O., Cordido F. Altered fasting and postprandial plasma ghrelin levels in patients with liver failure are normalized after liver transplantation. Eur J Endocrinol 2010, 163:609-616. [Epub 2010 July 8].
105. Diz-Lois M.T., Garcia-Buela J., Suarez F., Sangiao-Alvarellos S., Vidal O., Cordido F. Fasting and postprandial plasma ghrelin levels are decreased in patients with liver failure previous to liver transplantation. Endocrine 2009, 35:467-476. [Epub 2009 April 11].